HIV infection among persons who inject illicit drugs: Problems and prospects

Don Des Jarlais, Samuel R. Friedman

Research output: Contribution to journalArticle

Abstract

Intravenous drug use continues as the second most common risk behavior associated with acquired immune deficiency syndrome (AIDS) in the United States and Europe. Recently there has been increased public and research attention to this problem. Five areas of public health concern for AIDS among i.v. drug users are identified and discussed: (a) the potential spread of human immunodeficiency virus (HIV) to drug users in developing countries; (b) the emergence of cocaine use associated with HIV infection; (c) ethnic differences in seroprevalence rates among i.v. drug users, with ethnic minorities tending to have higher rates; (d) difficulties in changing the sexual behavior of i.v. drug users; and (e) an increased frequency of fatal infections among HIV seropositive drug users that are not counted with the current surveillance definition of AIDS. There have been numerous studies of AIDS risk reduction among i.v. drug users, but the ultimate effect of the behavior change on spread of the virus is not yet clear. Preliminary studies from New York City, San Francisco, and Stockholm indicate a relative stabilization of seroprevalence in those cities, suggesting that the behavior changes reported in those cities may be significantly slowing the rate of viral spread.

Original languageEnglish (US)
Pages (from-to)267-273
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume1
Issue number3
StatePublished - Jan 1 1988

Fingerprint

Street Drugs
Virus Diseases
Drug Users
HIV
Acquired Immunodeficiency Syndrome
Seroepidemiologic Studies
San Francisco
Risk Reduction Behavior
Risk-Taking
Cocaine
Sexual Behavior
Developing Countries
Public Health
Viruses
Infection
Research
Pharmaceutical Preparations

Keywords

  • HIV infection
  • Intravenous drug use

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

HIV infection among persons who inject illicit drugs : Problems and prospects. / Des Jarlais, Don; Friedman, Samuel R.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 1, No. 3, 01.01.1988, p. 267-273.

Research output: Contribution to journalArticle

@article{463d48a4ade0497ab5c4cb52bc395092,
title = "HIV infection among persons who inject illicit drugs: Problems and prospects",
abstract = "Intravenous drug use continues as the second most common risk behavior associated with acquired immune deficiency syndrome (AIDS) in the United States and Europe. Recently there has been increased public and research attention to this problem. Five areas of public health concern for AIDS among i.v. drug users are identified and discussed: (a) the potential spread of human immunodeficiency virus (HIV) to drug users in developing countries; (b) the emergence of cocaine use associated with HIV infection; (c) ethnic differences in seroprevalence rates among i.v. drug users, with ethnic minorities tending to have higher rates; (d) difficulties in changing the sexual behavior of i.v. drug users; and (e) an increased frequency of fatal infections among HIV seropositive drug users that are not counted with the current surveillance definition of AIDS. There have been numerous studies of AIDS risk reduction among i.v. drug users, but the ultimate effect of the behavior change on spread of the virus is not yet clear. Preliminary studies from New York City, San Francisco, and Stockholm indicate a relative stabilization of seroprevalence in those cities, suggesting that the behavior changes reported in those cities may be significantly slowing the rate of viral spread.",
keywords = "HIV infection, Intravenous drug use",
author = "{Des Jarlais}, Don and Friedman, {Samuel R.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "1",
pages = "267--273",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - HIV infection among persons who inject illicit drugs

T2 - Problems and prospects

AU - Des Jarlais, Don

AU - Friedman, Samuel R.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Intravenous drug use continues as the second most common risk behavior associated with acquired immune deficiency syndrome (AIDS) in the United States and Europe. Recently there has been increased public and research attention to this problem. Five areas of public health concern for AIDS among i.v. drug users are identified and discussed: (a) the potential spread of human immunodeficiency virus (HIV) to drug users in developing countries; (b) the emergence of cocaine use associated with HIV infection; (c) ethnic differences in seroprevalence rates among i.v. drug users, with ethnic minorities tending to have higher rates; (d) difficulties in changing the sexual behavior of i.v. drug users; and (e) an increased frequency of fatal infections among HIV seropositive drug users that are not counted with the current surveillance definition of AIDS. There have been numerous studies of AIDS risk reduction among i.v. drug users, but the ultimate effect of the behavior change on spread of the virus is not yet clear. Preliminary studies from New York City, San Francisco, and Stockholm indicate a relative stabilization of seroprevalence in those cities, suggesting that the behavior changes reported in those cities may be significantly slowing the rate of viral spread.

AB - Intravenous drug use continues as the second most common risk behavior associated with acquired immune deficiency syndrome (AIDS) in the United States and Europe. Recently there has been increased public and research attention to this problem. Five areas of public health concern for AIDS among i.v. drug users are identified and discussed: (a) the potential spread of human immunodeficiency virus (HIV) to drug users in developing countries; (b) the emergence of cocaine use associated with HIV infection; (c) ethnic differences in seroprevalence rates among i.v. drug users, with ethnic minorities tending to have higher rates; (d) difficulties in changing the sexual behavior of i.v. drug users; and (e) an increased frequency of fatal infections among HIV seropositive drug users that are not counted with the current surveillance definition of AIDS. There have been numerous studies of AIDS risk reduction among i.v. drug users, but the ultimate effect of the behavior change on spread of the virus is not yet clear. Preliminary studies from New York City, San Francisco, and Stockholm indicate a relative stabilization of seroprevalence in those cities, suggesting that the behavior changes reported in those cities may be significantly slowing the rate of viral spread.

KW - HIV infection

KW - Intravenous drug use

UR - http://www.scopus.com/inward/record.url?scp=0024216767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024216767&partnerID=8YFLogxK

M3 - Article

C2 - 3216310

AN - SCOPUS:0024216767

VL - 1

SP - 267

EP - 273

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -